On Wednesday, the European Commission gave the green light to the purchase of 200 million doses from the American biotech company Novavax. According to Dirk Ramaekers, head of the Vaccination Task Force, the new vaccine can be an alternative to the existing one.
–
Commission chairwoman Ursula von der Leyen announced the news on Wednesday afternoon. Europe signed a contract with Novavax to supply 100 million vaccines, with an option to purchase a further 100 million…
–
